VIA DISC NP KEY FEATURES
VIVEX is expanding our Amnion & Wound Care Distribution Network. Interested in becoming a distribution partner? Click here to learn more.
Minimally Invasive Procedure
VIA Disc NP is a minimally invasive procedure that can be delivered through a 20G spine needle.
Ease of Use
Off-the-shelf allogeneic graft for ease of use.
Supplements the Disc
In-vitro testing of nucleus pulposus tissue demonstrates ability of disc to absorb water similar to original nucleus pulposus tissue. Transplanted nucleus pulposus tissue may support biomechanical function of the supplemented disc.
Proprietary Container for Allograft Preparation
Consistent mixing in fully closed container to reduce contamination risk.
HOW VIA DISC NP® WORKS
Age-related wear and tear of the intervertebral disc can cause loss of hydration and degeneration.
VIA Disc NP is delivered into the degenerated intervertebral disc through a 20G spine needle.
After delivery, VIA Disc NP supports the natural cushioning function and supplements tissue loss in the degenerated intervertebral disc.
PROCEDURE
The VIA Disc NP procedure is intended for patients who have experienced tissue loss within their lumbar intervertebral discs. The procedure involves fluoroscopy imaging to guide a spinal needle through Kambin’s safe triangle into the nucleus pulposus of the intervertebral disc. The VIA Disc NP allograft is delivered into the target disc to rehydrate and support the cushioning function of the disc.
DISC DEGENERATION
Disc degeneration typically begins within the nucleus puplosus (NP). Over time, the NP begins to lose its ability to absorb water and nutrients, leading to decreased disc height. Degenerated discs are characterized by decreased disc height, loss of water content and loss of nutrient content.
VIVEX BIOLOGICS: THE SCIENCE OF EXTRAORDINARY
VIVEX develops and delivers innovative allografts designed to support the body’s healing potential to help improve patient outcomes and quality of life. Our medical technologies date back 50 years to the founding of The University of Miami Tissue Bank in 1970. Since that time, we have experienced multiple firsts in clinical and scientific achievements. VIVEX’s strategic plan is focused on the development of new innovative allografts, research and development, enhancement of manufacturing capabilities, and sales and marketing efforts.
CONNECT WITH US
GET STARTED
